NSE:APOLLOHOSP (India)
Â
Ordinary Shares
₹
5948.25
(-0.08%)
May 21
Current and historical daily PE Ratio for Apollo Hospitals Enterprise Ltd (
NSE:APOLLOHOSP
) from 1996 to May 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Apollo Hospitals Enterprise stock (NSE:APOLLOHOSP) PE ratio as of May 22 2024 is 108.32.
More Details
Apollo Hospitals Enterprise Ltd (NSE:APOLLOHOSP) PE Ratio (TTM) Chart
Apollo Hospitals Enterprise Ltd (NSE:APOLLOHOSP) PE Ratio (TTM) Historical Data
View and export this data going back to 1996. Start your Free Trial
Total 1279
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Apollo Hospitals Enterprise PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-22 | 108.3 | 2024-03-19 | 111.3 |
| 2024-05-21 | 108.3 | 2024-03-18 | 111.8 |
| 2024-05-17 | 108.4 | 2024-03-15 | 109.0 |
| 2024-05-16 | 108.0 | 2024-03-14 | 109.7 |
| 2024-05-15 | 106.5 | 2024-03-13 | 109.4 |
| 2024-05-14 | 106.8 | 2024-03-12 | 111.9 |
| 2024-05-13 | 106.2 | 2024-03-11 | 113.0 |
| 2024-05-10 | 106.4 | 2024-03-08 | 110.2 |
| 2024-05-09 | 105.7 | 2024-03-07 | 110.2 |
| 2024-05-08 | 106.5 | 2024-03-06 | 110.3 |
| 2024-05-07 | 107.5 | 2024-03-05 | 110.4 |
| 2024-05-06 | 110.3 | 2024-03-04 | 109.9 |
| 2024-05-03 | 109.4 | 2024-03-01 | 110.8 |
| 2024-05-02 | 108.5 | 2024-02-29 | 111.1 |
| 2024-05-01 | 108.3 | 2024-02-28 | 115.9 |
| 2024-04-30 | 108.3 | 2024-02-27 | 120.6 |
| 2024-04-29 | 108.7 | 2024-02-26 | 119.9 |
| 2024-04-26 | 114.0 | 2024-02-23 | 123.4 |
| 2024-04-25 | 116.3 | 2024-02-22 | 123.3 |
| 2024-04-24 | 114.4 | 2024-02-21 | 123.1 |
| 2024-04-23 | 112.8 | 2024-02-20 | 123.1 |
| 2024-04-22 | 113.6 | 2024-02-19 | 121.2 |
| 2024-04-19 | 112.4 | 2024-02-16 | 120.2 |
| 2024-04-18 | 110.6 | 2024-02-15 | 120.7 |
| 2024-04-17 | 115.4 | 2024-02-14 | 123.0 |
| 2024-04-16 | 115.4 | 2024-02-13 | 122.4 |
| 2024-04-15 | 114.8 | 2024-02-12 | 120.5 |
| 2024-04-12 | 116.7 | 2024-02-09 | 117.2 |
| 2024-04-11 | 118.2 | 2024-02-08 | 113.5 |
| 2024-04-10 | 118.2 | 2024-02-07 | 112.5 |
| 2024-04-09 | 118.5 | 2024-02-06 | 112.9 |
| 2024-04-08 | 114.9 | 2024-02-05 | 113.5 |
| 2024-04-05 | 116.5 | 2024-02-02 | 115.1 |
| 2024-04-04 | 117.3 | 2024-02-01 | 114.5 |
| 2024-04-03 | 116.1 | 2024-01-31 | 115.7 |
| 2024-04-02 | 116.9 | 2024-01-30 | 114.9 |
| 2024-04-01 | 117.6 | 2024-01-29 | 115.3 |
| 2024-03-29 | 115.8 | 2024-01-26 | 112.3 |
| 2024-03-28 | 115.8 | 2024-01-25 | 112.3 |
| 2024-03-27 | 113.5 | 2024-01-24 | 113.2 |
| 2024-03-26 | 115.1 | 2024-01-23 | 112.1 |
| 2024-03-25 | 116.1 | 2024-01-22 | 111.0 |
| 2024-03-22 | 116.1 | 2024-01-19 | 111.0 |
| 2024-03-21 | 112.6 | 2024-01-18 | 109.1 |
| 2024-03-20 | 112.4 | 2024-01-17 | 107.9 |
Apollo Hospitals Enterprise Ltd (NSE:APOLLOHOSP) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Apollo Hospitals Enterprise Ltd
ISIN : INE437A01024
Share Class Description:
NSE:APOLLOHOSP: Ordinary SharesCompare
Compare
Traded in other countries / regions
APOLLOHOSP.India IPO Date
1996-01-10Description
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. The firm receives the most proportion of revenue from its core healthcare business. The firm's standalone pharmacy segment contributes the second largest proportion of revenue.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers